Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone.
Publication/Presentation Date
6-1-2023
Abstract
Kratom is an unregulated herbal supplement that is growing in popularity in the United States. Its primary active ingredients, mitragynine, and 7-hydroxymitragynine, are partial agonists that act on mu- and delta-opioid receptors in the central nervous system, producing analgesia and a sense of euphoria. Kratom use can lead to addiction and adverse side effects, such as seizures, hallucinations, and coma. This case report presents a male in his 40s with a history of kratom use, who presented to the clinic seeking help for his addiction. The patient had been using kratom for several years to self-medicate for his anxiety and depression and gradually developed a kratom addiction. The patient was successfully treated with buprenorphine/naloxone, which helped alleviate his withdrawal symptoms and allowed him to abstain from kratom. This case underscores the growing issue of kratom addiction in the United States and the critical need for physician awareness in treating withdrawal.
Volume
15
Issue
6
First Page
41146
Last Page
41146
ISSN
2168-8184
Published In/Presented At
Arhin, M., Mobley, J., Hamad, H., & Remick, P. (2023). Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone. Cureus, 15(6), e41146. https://doi.org/10.7759/cureus.41146
Disciplines
Medicine and Health Sciences
PubMedID
37519540
Department(s)
Fellows and Residents
Document Type
Article